A central role for mesangial cells in the initiation of diabetic nephropathy
Kidney International · 2023
DOI: 10.1016/j.kint.2023.03.033 ↗Kurz gefasst
Kommentar in der Zeitschrift Kidney International, 2023. Verfasst von Zhengying Fang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Barbara T. Murphy Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Nep…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Barbara T. Murphy Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medi…
- Department of Medicine, Barbara T. Murphy Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: kim.lee@mssm.edu.
- Department of Medicine, Barbara T. Murphy Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Renal Section, James J. Peters Veterans Affair Medical Center, Bronx, New York, USA. El…
Förderung
- NIDDK NIH HHS
Zitieren
APA
Fang, Z., Lee, K., & He, J. C. (2023). A central role for mesangial cells in the initiation of diabetic nephropathy. Kidney International. https://doi.org/10.1016/j.kint.2023.03.033
Vancouver
Fang Z, Lee K, He JC. A central role for mesangial cells in the initiation of diabetic nephropathy. Kidney International. 2023. doi:10.1016/j.kint.2023.03.033
BibTeX
@article{Fang2023,
author = {Fang, Zhengying and Lee, Kyung and He, John Cijiang},
title = {A central role for mesangial cells in the initiation of diabetic nephropathy},
journal = {Kidney International},
year = {2023},
doi = {10.1016/j.kint.2023.03.033}
}
EUVIMED